vs
Side-by-side financial comparison of Climb Global Solutions, Inc. (CLMB) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
USANA HEALTH SCIENCES INC is the larger business by last-quarter revenue ($226.2M vs $182.4M, roughly 1.2× Climb Global Solutions, Inc.). Climb Global Solutions, Inc. runs the higher net margin — 1.8% vs 0.1%, a 1.7% gap on every dollar of revenue. On growth, Climb Global Solutions, Inc. posted the faster year-over-year revenue change (32.1% vs -10.0%). Over the past eight quarters, Climb Global Solutions, Inc.'s revenue compounded faster (40.7% CAGR vs 3.1%).
Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
CLMB vs USNA — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $182.4M | $226.2M |
| Net Profit | $3.3M | $180.0K |
| Gross Margin | 14.5% | 78.2% |
| Operating Margin | 2.1% | 1.7% |
| Net Margin | 1.8% | 0.1% |
| Revenue YoY | 32.1% | -10.0% |
| Net Profit YoY | -9.5% | -74.0% |
| EPS (diluted) | $0.18 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $182.4M | — | ||
| Q4 25 | $193.8M | $226.2M | ||
| Q3 25 | $161.3M | $213.7M | ||
| Q2 25 | $159.3M | $235.8M | ||
| Q1 25 | $138.0M | $249.5M | ||
| Q4 24 | $161.8M | $213.6M | ||
| Q3 24 | $119.3M | $200.2M | ||
| Q2 24 | $92.1M | $212.9M |
| Q1 26 | $3.3M | — | ||
| Q4 25 | $7.0M | $180.0K | ||
| Q3 25 | $4.7M | $-6.5M | ||
| Q2 25 | $6.0M | $9.7M | ||
| Q1 25 | $3.7M | $9.4M | ||
| Q4 24 | $7.0M | $4.5M | ||
| Q3 24 | $5.5M | $10.6M | ||
| Q2 24 | $3.4M | $10.4M |
| Q1 26 | 14.5% | — | ||
| Q4 25 | 15.4% | 78.2% | ||
| Q3 25 | 15.9% | 77.2% | ||
| Q2 25 | 16.5% | 78.7% | ||
| Q1 25 | 16.9% | 79.0% | ||
| Q4 24 | 19.3% | 82.0% | ||
| Q3 24 | 20.3% | 80.4% | ||
| Q2 24 | 20.2% | 81.1% |
| Q1 26 | 2.1% | — | ||
| Q4 25 | 4.9% | 1.7% | ||
| Q3 25 | 4.3% | 0.6% | ||
| Q2 25 | 5.0% | 7.1% | ||
| Q1 25 | 3.5% | 6.3% | ||
| Q4 24 | 7.2% | 3.8% | ||
| Q3 24 | 7.1% | 7.8% | ||
| Q2 24 | 4.6% | 8.4% |
| Q1 26 | 1.8% | — | ||
| Q4 25 | 3.6% | 0.1% | ||
| Q3 25 | 2.9% | -3.1% | ||
| Q2 25 | 3.7% | 4.1% | ||
| Q1 25 | 2.7% | 3.8% | ||
| Q4 24 | 4.3% | 2.1% | ||
| Q3 24 | 4.6% | 5.3% | ||
| Q2 24 | 3.7% | 4.9% |
| Q1 26 | $0.18 | — | ||
| Q4 25 | $1.51 | $-0.10 | ||
| Q3 25 | $1.02 | $-0.36 | ||
| Q2 25 | $1.30 | $0.52 | ||
| Q1 25 | $0.81 | $0.49 | ||
| Q4 24 | $1.52 | $0.23 | ||
| Q3 24 | $1.19 | $0.56 | ||
| Q2 24 | $0.75 | $0.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.8M | $158.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $118.4M | — |
| Total Assets | $458.8M | $742.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $41.8M | — | ||
| Q4 25 | $36.6M | $158.4M | ||
| Q3 25 | $49.8M | $145.3M | ||
| Q2 25 | $28.6M | $151.3M | ||
| Q1 25 | $32.5M | $179.6M | ||
| Q4 24 | $29.8M | $181.8M | ||
| Q3 24 | $22.1M | $364.9M | ||
| Q2 24 | $48.4M | $332.4M |
| Q1 26 | $118.4M | — | ||
| Q4 25 | $116.6M | — | ||
| Q3 25 | $109.3M | $528.1M | ||
| Q2 25 | $105.2M | $531.1M | ||
| Q1 25 | $95.6M | $529.8M | ||
| Q4 24 | $90.6M | $532.1M | ||
| Q3 24 | $87.7M | $533.1M | ||
| Q2 24 | $79.8M | $512.2M |
| Q1 26 | $458.8M | — | ||
| Q4 25 | $460.2M | $742.9M | ||
| Q3 25 | $376.1M | $726.6M | ||
| Q2 25 | $420.7M | $734.5M | ||
| Q1 25 | $370.1M | $746.6M | ||
| Q4 24 | $469.2M | $748.2M | ||
| Q3 24 | $371.9M | $671.3M | ||
| Q2 24 | $302.8M | $631.4M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
